Convertible Note - Ligandal

Convertible Note - Ligandal

Investment Firm

Overview

Ligandal is creating delivery systems and AI-driven targeting approaches for cell-specific and precision genetic medicine.

Announced Date

Jan 14, 2014

Funding Type

Convertible Note

Highlights

Location

New York, United States, North America

Social

Investor Lead

N/A

Participant Investors

3

Investor Name
Participant InvestorAlex Pesch
Participant InvestorNick Conley
Participant InvestorMiron Cuperman

Round Details and Background

Ligandal raised $64000 on 2014-01-14 in Convertible Note

Ligandal is creating delivery systems and AI-driven targeting approaches for cell-specific and precision genetic medicine.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 09, 2016
Angel Round - Ligandal
10-330.0K
Aug 06, 2015
Angel Round - Ligandal
1-200.0K
Jan 01, 2015
Angel Round - Ligandal
3-250.0K
Jan 14, 2014
Convertible Note - Ligandal
3-64.0K

Recent Activity

There is no recent news or activity for this profile.